Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication

W A Bresnahan1, I Boldogh, P Chi

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston 77550, USA.

Virology
|May 12, 1997
PubMed

Insights

Human cytomegalovirus (HCMV) requires cellular cyclin-dependent kinase 2 (Cdk2) for replication. Inhibiting Cdk2 activity blocks HCMV DNA synthesis, progeny production, and viral antigen expression, indicating Cdk2 is essential for the virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that manipulates host cellular processes.
  • Cellular cyclin-dependent kinase 2 (Cdk2) plays a crucial role in regulating the cell cycle at the G1 and S phases.

Purpose of the Study:

  • To investigate the necessity of cellular Cdk2 activity for HCMV replication.
  • To determine if inhibiting Cdk2 impacts HCMV infection outcomes.

Main Methods:

  • Inhibition of Cdk2 activity using the specific inhibitor roscovitine.
  • Expression of a dominant-negative Cdk2 mutant in infected cells.
  • Assessment of HCMV DNA synthesis, infectious progeny production, and late antigen expression.

Main Results:

  • Roscovitine treatment inhibited HCMV DNA synthesis, progeny production, and late antigen expression in a dose-dependent manner.
  • Expression of a dominant-negative Cdk2 mutant significantly blocked HCMV replication.
  • Expression of wild-type Cdk2 did not affect viral replication.

Conclusions:

  • Cellular Cdk2 activation is a necessary event for successful HCMV replication.
  • Targeting Cdk2 activity represents a potential antiviral strategy against HCMV infections.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...